Ticker
2CUREX.ST

Price
10.22
Stock movement down
-0.22 (-2.11%)
Company name
2cureX AB
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Biotechnology
Market cap
179.90M
Ent value
119.44M
Price/Sales
-
Price/Book
2.70
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-37.45%
3 year return
-12.39%
5 year return
-
10 year return
-
Last updated: 2022-08-25

DIVIDENDS

2CUREX.ST does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book2.70
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count17.60M
EPS (TTM)-1.42
FCF per share (TTM)-1.35

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)-9.35M
Operating income (TTM)-28.27M
Net income (TTM)-25.00M
EPS (TTM)-1.42
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash63.35M
Net receivables5.66M
Total current assets69.01M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets69.63M
Accounts payable0.00
Short/Current long term debt0.00
Total current liabilities2.89M
Total liabilities2.89M
Shareholder's equity66.75M
Net tangible assets66.75M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-23.65M
Capital expenditures (TTM)96.00K
Free cash flow (TTM)-23.75M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-37.45%
Return on Assets-35.90%
Return on Invested Capital-37.45%
Cash Return on Invested Capital-35.58%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open10.44
Daily high11.36
Daily low10.00
Daily Volume41K
All-time high28.20
1y analyst estimate-
Beta0.88
EPS (TTM)-1.42
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
2CUREX.STS&P500
Current price drop from All-time high-63.76%-12.18%
Highest price drop-63.76%-56.47%
Date of highest drop25 Aug 20229 Mar 2009
Avg drop from high-28.36%-11.38%
Avg time to new high52 days12 days
Max time to new high457 days1805 days
COMPANY DETAILS
2CUREX.ST (2cureX AB) company logo
Marketcap
179.90M
Marketcap category
Small-cap
Description
2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. The company is also conducting various clinical programs for IndiTreat for breast colorectal, ovarian, and pancreatic cancers. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
Employees
14
Investor relations
-
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found